IM Cannabis CorpIMCC
Price$2.17

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $39.9M+6.4% YoYTTM through 31 Dec 2025
Net Income -$8.3MTTM through 31 Dec 2025
Free Cash Flow $3.4MTTM through 31 Dec 2025

Margins

Current
Gross Margin17.7%
EBITDA Margin-22.0%
Operating Margin-21.2%
Net Margin-20.7%

Returns

325.0%ROE
-37.0%ROA

Balance Sheet Health

Debt / Equity-4.14x
Current Ratio0.67x
Net Debt$12.2M
Cash & Equivalents$2.7M

Quality Metrics

Piotroski F-Score4 / 9
FCF Margin8.6%
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $54.7M
Diluted EPS
'21'22'23
FY2023: $-0.80

Dividend

No dividend

Capital Allocation

Capex Intensity0.0%
Financials converted at 1.3695 from CAD.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.